S. D’Adamio - Concepedia

Author

S. D’Adamio

Also Known As

D&#039;Adamio,S, S D'Adamio, S. D'Adamio, S. D’Adamio, S. D’adamio, S., D'Adamio, Simone D'Adamio, Simone D’ADAMIO, Simone D’Adamio, Simone D’adamio

Publications

610

Citations

H-Index

Concepts

All Affiliations

University of Rome Tor Vergata Università Cattolica del Sacro Cuore

About

S. D’Adamio is an author at University of Rome Tor Vergata specializing in autoimmune disease, dermatopathology, and rheumatoid arthritis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	39
2	Immunology	2	2	39
3	Autoimmune Disease	2	2	39
4	Autoimmunity	2	2	39
5	Immunotherapy	1	1	11

S. D’Adamio

Publications

276

Citations

H-Index

Page 1

	Year	Citations
Secukinumab in moderate-to-severe plaque psoriasis: a multi-center, retrospective, real-life study up to 52 weeks observation Marco Galluzzo, Marina Talamonti, Clara De Simone, Expert Opinion on Biological Therapy	2018	65
In which patients the best efficacy of secukinumab? Update of a real-life analysis after 136 weeks of treatment with secukinumab in moderate-to-severe plaque psoriasis Marco Galluzzo, S. D’Adamio, Dionisio Silvaggio, Expert Opinion on Biological Therapy	2019	52
Alexithymia and Plaque Psoriasis: Preliminary Investigation in a Clinical Sample of 250 Patients Marina Talamonti, Marco Galluzzo, Stella Servoli, Dermatology	2016	37
A clinical case of severe disease burden: an erythrodermic psoriatic patient treated with secukinumab Marco Galluzzo, S. D’Adamio, Elena Campione, Journal of Dermatological Treatment InflammationAutoimmune DiseaseMedicineSecukinumab TreatmentClinical Case	2018	28
<p>Spotlight on brodalumab in the treatment of plaque psoriasis: the evidence to date</p> Marco Galluzzo, S. D’Adamio, Antonio Massaro, Clinical Cosmetic and Investigational Dermatology	2019	25
Ustekinumab treatment for moderate-to-severe plaque psoriasis: eight-year real-life experience Marco Galluzzo, S. D’Adamio, Dionisio Silvaggio, Expert Opinion on Biological Therapy	2019	20
Effect of anti IL-12/23 on body composition: results of bioelectrical impedance analysis in Caucasian psoriatic patients Marco Galluzzo, S. D’Adamio, Roberta Pastorino, Expert Opinion on Biological Therapy	2017	19
Guselkumab for the treatment of psoriasis: a 60-week real-life multicenter retrospective experience Federico Bardazzi, Filippo Viviani, Yuri Merli, Expert Opinion on Biological Therapy	2022	19
Treating a Multidrug-Resistant Psoriatic HLA-C*18:01 Allele Carrier with Combination Ustekinumab Apremilast Therapy Marco Galluzzo, S. D’Adamio, Elena Campione, Molecular Diagnosis & Therapy Autoimmune DiseaseMedicineImmunologyClinical DermatologyAutoimmunity	2018	11

Page 1